Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Nerve growth factor levels and localisation in human asthmatic bronchi

C. Olgart Höglund, F. de Blay, J-P. Oster, C. Duvernelle, O. Kassel, G. Pauli, N. Frossard
European Respiratory Journal 2002 20: 1110-1116; DOI: 10.1183/09031936.02.00205402
C. Olgart Höglund
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. de Blay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-P. Oster
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Duvernelle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. Kassel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. Pauli
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
N. Frossard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Tables
  • Fig. 1.—
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.—

    Nerve growth factor (NGF) protein levels in bronchoalveolar fluid from control subjects and asthmatic patients. NGF levels were quantified by enzy-melinked immunosorbent assay. Individual values are represented as dots and bars indicate mean±sem*. : p<0.05 between groups.

  • Fig. 2.—
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.—

    Nerve growth factor (NGF) immunolocalisation on bronchial biopsy sections from control subjects (a, b) and asthmatic patients (c–f). Intense labelling was observed in bronchial epithelium (Ep), smooth muscle cells (Smc) and infiltrating inflammatory cells (Ic) in the submucosa, showing cytoplasmic localisation, both in control subjects and asthmatic patients. A negative control is shown (f), where the anti-human NGF antibody was replaced by its control isotype immunoglobulin.

Tables

  • Figures
  • Table 1—

    Clinical characteristics of patients with asthma

    Subject no.AgeSexSmoking habitsAllergy/atopyFEV1 % predPD20 µg
    121FC#Cat, dog, grass9336
    225MNoneMite83.872
    322MNoneCat, mite61.018
    426FNoneCat102.91620
    524FC¶Cat, grass, mite78.2360
    624FNoneNone97.11620
    722MNoneBirch, mite, mould, food+75.01620
    • FEV1: forced expiratory volume in one second

    • PD20: provocation dose causing a 20% fall in FEV1

    • M: male

    • F: female

    • C: current smoker

    • #: 10

    • and ¶: 15 cigarettes·day−1

    • +: coriander

  • Table 2—

    Clinical characteristics of control subjects

    Subject no.AgeSexSmoking habitsAllergy/atopyFEV1 % predPD20 µg
    138MONone90.3>2340
    225MONone101.8>2340
    321FC#None95.1>2340
    428MC¶None99.4>2340
    526FNoneNone103.6>2340
    623FNoneNone113.1>2340
    724FNoneNone102.2>2340
    • FEV1: forced expiratory volume in one second

    • PD20: provocation dose causing a 20% fall in FEV1

    • M: male

    • F: female

    • O: occasional smoker

    • C: current smoker

    • #: 10

    • and ¶·: 15 cigarettesday−1

  • Table 3—

    Cells in bronchoalveolar lavage

    Control subjectsPatients with asthma
    Total cell concentration 106·L−1±8031±239186
    %Macrophages ±951±923
    %Lymphocytes ±40.8±63
    %Neutrophils ±10.4±0.80.4
    %Eosinophils ±0.20.1±0.30.2
    %Epithelial cells ±0.50.3±0.10.1
    • Data are presented as means±sem

PreviousNext
Back to top
View this article with LENS
Vol 20 Issue 5 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nerve growth factor levels and localisation in human asthmatic bronchi
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Nerve growth factor levels and localisation in human asthmatic bronchi
C. Olgart Höglund, F. de Blay, J-P. Oster, C. Duvernelle, O. Kassel, G. Pauli, N. Frossard
European Respiratory Journal Nov 2002, 20 (5) 1110-1116; DOI: 10.1183/09031936.02.00205402

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Nerve growth factor levels and localisation in human asthmatic bronchi
C. Olgart Höglund, F. de Blay, J-P. Oster, C. Duvernelle, O. Kassel, G. Pauli, N. Frossard
European Respiratory Journal Nov 2002, 20 (5) 1110-1116; DOI: 10.1183/09031936.02.00205402
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Material and methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Parental occupation is a risk factor for childhood wheeze and asthma
  • Aerobic training reverses airway inflammation and remodelling in an asthma murine model
  • Variability in the prevalence of premenstrual asthma
Show more Original Articles: Asthma

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society